Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| ENT0080 | Other Identifier | OnCore |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Goldman Sachs Foundation | UNKNOWN |
| Wallace H. Coulter Foundation | OTHER |
| Emerson Collective | UNKNOWN |
Not provided
Not provided
The purpose of this study is to gain initial experience imaging HNC patient using a new PET camera, a 1mm spacial resolution. The goal is to understand image quality of the system and to see how it works in a clinical environment.
PRIMARY OBJECTIVE(S): Gain initial experience imaging head/neck cancer patients using a novel PET camera comprising two opposing panels with 1 millimeter spatial resolution.
SECONDARY OBJECTIVE(S):
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Novel PET Camera | Experimental | Patients already undergoing a PET/CT scan for HNC will afterwards undergo a PET scan with the proposed device, thus no additional radioactivity is needed as part of this study. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 1-mm Resolution Clinical PET camera | Device | 1-Millimeter Resolution Clinical PET System in Head and Neck Cancer (HNC) Imaging |
|
| Measure | Description | Time Frame |
|---|---|---|
| Acquiring PET images of HNC patients with the 1 mm resolution PET imaging device. | PET images of HNC patients with the 1 mm resolution PET imaging device will be qualitatively accessed whether the camera can visualize the primary lesion, including heterogeneity and lymph nodes will be assessed. | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Measure image quality of the 1 mm resolution PET imaging device | Image quality of the 1 mm resolution PET imaging device (scale 1-5) with 5 being highest 'image quality' will be assessed to understand radioactive dose and scan time required for a given desired image quality. | Day 1 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
1. Additional condition, or extenuating circumstance that, in the opinion of the investigator, may interfere with study compliance.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Grace Yi | Contact | 650-242-2666 | gracesyi@stanford.edu |
| Name | Affiliation | Role |
|---|---|---|
| Eben Rosenthal, Ph.D | Stanford Universiy | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Stanford University | Stanford | California | 94304 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006258 | Head and Neck Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided